Electroclinical syndrome, etiology, and early treatment response are the strongest prognostic anchors.
After a first unprovoked seizure
Recurrence risk is driven by EEG abnormalities, structural lesions, and etiology; many children do not require immediate maintenance therapy [11], [12].
Discuss safety, rescue plans, and follow-up EEG/MRI as indicated [11], [12].
Syndrome matters
Self-limited focal epilepsies often remit in adolescence; symptomatic epilepsies carry higher persistence and comorbidity risks [8], [4], [5].
In long-term cohorts of childhood-onset epilepsy, a substantial proportion achieve remission, but outcomes vary by underlying cause [4], [5].
Infantile epileptic spasms syndrome (IESS)
Treat urgently with hormonal therapy (ACTH or high-dose steroids) and/or vigabatrin; delayed control is linked to worse developmental outcomes [7].
Monitor for adverse effects of hormonal therapy and vigabatrin; adjust rapidly based on EEG/clinical response [7].
Drug resistance and escalation
Despite adequate therapy, about 30% of children remain uncontrolled and may need rescue plans, dietary therapy, devices, or surgery [2], [9].
Early referral to comprehensive epilepsy centers enables presurgical evaluation and individualized therapy [9], [3], [10].
Surgical outcomes
Pooled pediatric surgical series show seizure freedom of about 64.8% at 1 year (95% CI 51.2–76.4) with modest decline over time [3].
Contemporary cohorts report ~80% seizure freedom at 1 year after last surgery with optimized pathways [10].